NAD+ price in 2026: what research-grade vials cost

This page compares what US research suppliers list for research-grade NAD+, per vial and per mg, as checked on November 17, 2026, and explains what moves the price.

Buying guide7 min read

Key takeaway

Research-grade NAD+ is a laboratory reagent sold by vial size. On November 17, 2026, the US research suppliers we checked listed it at $35.00 to $100.00 per 500 mg vial, and at $0.07 to $0.47 per mg across 100 mg to 1,000 mg vials. Vitrapep lists a 500 mg vial at $74.99. All of it is laboratory research material, not for human or veterinary use.

At a glance

Article typeBuying guide
Main guideNAD+: complete guide
Regulatory statusNot FDA-approved“Regulatory: NAD+ itself has no FDA approval” (NAD+: complete guide)
ClassCell metabolism & aging
Body systemsEndocrine & metabolism
Studies cited0 in this article · 20 across 5 articles on NAD+
ProductNAD+ product page

NAD+ price questions often lead to research suppliers that sell it alongside peptides. NAD+ is not a peptide, but it is sold the same way: as a lyophilized powder in sealed vials, for laboratory research use only. This page sets out what US research suppliers listed on November 17, 2026, per vial and per mg, what moves the price, and which listings deserve a closer look.

Quick answer: Research-grade NAD+ listed at $35.00–$100.00 per 500 mg vial at the US suppliers we checked on November 17, 2026. Per mg, prices ran from $0.07 to $0.47, with small vials the most expensive per mg. Vitrapep lists 500 mg at $74.99, or $0.15 per mg. For sourcing questions, see where to buy NAD+.

What research-grade NAD+ is

NAD+ is nicotinamide adenine dinucleotide, listed in PubChem as nadide, with the formula C21H27N7O14P2 and a molecular weight of 663.4 (PubChem). It is a small molecule, not a chain of amino acids. Research suppliers sell it as a freeze-dried powder in vials from 100 mg to 1,000 mg. For the published research on the compound, see our NAD+ research guide.

On FDA’s May 14, 2026 list of substances nominated for pharmacy compounding under section 503A, “Nicotinamide Adenine Dinucleotide (NAD)” sits in category 1, bulk drug substances under evaluation. A salt form, beta-nicotinamide adenine dinucleotide disodium salt trihydrate, sits in category 3, substances nominated without adequate support (FDA, 2026). FDA treats the two forms as separate substances.

Research-grade NAD+ is a reagent for laboratory work. It is for laboratory research use only, not for human or veterinary use. Our explainer on research use only labeling covers what that label means.

What US research suppliers list in November 2026

We checked supplier product pages on November 17, 2026, and recorded the listed single-vial price for each size the page showed. Prices exclude shipping, codes and multi-vial discounts. Sprays, tablets, strips and blends are left out.

Table 1

Research-grade NAD+ prices at US suppliers, checked November 17, 2026

Supplier Vial size Listed price Price per mg
MyPurePeptide500 mg$35.00$0.07
Purely Peptides (listed as NAD+ Buffered)500 mg$49.99$0.10
PS Peptides100 mg$29.99$0.30
PS Peptides500 mg$79.99$0.16
PS Peptides1,000 mg$105.99$0.11
American Peptides500 mg$100.00$0.20
Core Peptides100 mg$47.00$0.47
Core Peptides250 mg$103.00$0.41
Core Peptides750 mg$292.00$0.39
Vitrapep500 mg$74.99$0.15

Sources: supplier product pages listed in the references, read November 17, 2026. Price per mg is the listed price divided by the vial size, rounded to the cent. PS Peptides per-size prices are from the store’s own data for the listing. Core Peptides shows a $47.00–$292.00 range; the per-size prices come from its discount tables. Purely Peptides does not say what the buffer is. American Peptides showed no price for its 1,000 mg size. All of these products are sold for laboratory research use only.

Three patterns stand out. First, 500 mg vials ran from $35.00 to $100.00, nearly a threefold gap for the same labeled amount. Second, larger vials cost less per mg at both suppliers selling several sizes: at PS Peptides, $0.30 per mg at 100 mg against $0.11 at 1,000 mg. Third, Vitrapep’s $74.99 sits in the middle of the five 500 mg listings.

What drives the price spread

Several costs sit behind every vial, and suppliers carry them differently. Our peptide prices explainer covers them across the whole catalog. NAD+ is not built residue by residue like a peptide, so chain length does not set its cost. Other levers do.

  • Form and formulation. Listings describe NAD+ differently: two in our check describe the free acid, one a “buffered” powder, and FDA treats a disodium salt as a separate substance. A vial labeled 500 mg of a salt or buffered mix may hold less NAD+ itself than 500 mg of the free acid.
  • Purity. Raising HPLC purity means discarding more of each batch during purification. Higher purity costs more per mg delivered.
  • Third-party testing. Identity and purity testing at an outside laboratory is a cost paid on every lot. Suppliers that skip outside testing skip that cost.
  • Vial size. Filling, capping, labeling and testing a vial cost about the same at 100 mg or 1,000 mg. Spread over more milligrams, those fixed costs shrink per mg, which is why the 100 mg vials in Table 1 are the most expensive per mg.
  • Promotions. Quantity discounts and site-wide codes change the effective price from week to week. MyPurePeptide offered 25% off ten or more vials, and Purely Peptides 5% to 20% off two or more.

Red flags in very cheap listings

A low price is not proof of a problem. The lowest listing we found, $35.00 for a 500 mg vial, showed a dated third-party report of measured content on its product page. What matters is what the seller documents. These signs deserve a closer look:

  • No lot-specific certificate. A credible certificate names the lot, the laboratory, the test date, purity and an identity result. One listing in our check said no third-party certificate had been published for the compound yet. Our guide to reading a certificate of analysis walks through each field.
  • No measured content. Fill weight can differ from the label in either direction. One report we saw measured 617.62 mg in a vial labeled 500 mg. A certificate should state what was measured.
  • An undefined formulation. If a listing says “buffered” or names a salt without giving the composition, the amount of NAD+ itself in the vial is unclear.
  • The wrong compound. NAD+ and its reduced form, NADH, are listed separately by FDA. A listing should name NAD+ and give the formula C21H27N7O14P2.
  • Human-use language. In a June 2023 warning letter to an online seller, FDA wrote that despite “research purpose only” and “not for human consumption” labels, evidence from the seller’s website showed the products were intended as drugs for human use (FDA, 2023). A research listing should carry no such claims.

What Vitrapep charges for NAD+

Vitrapep lists NAD+ as a 500 mg lyophilized vial at $74.99, which works out to $0.15 per mg. Store prices may still change before launch. The product page lists the compound’s molecular formula and weight. It is sold for laboratory research use only and is not for human or veterinary use. For a side-by-side look at sourcing questions, see where to buy NAD+, and for prices across the catalog, our peptide price list.

NAD+

Lyophilized Lot documentation Research use only

Specifications and the current lot’s test documentation for the NAD+ sold for laboratory research.

View NAD+ specifications

Frequently asked questions about NAD+ price

How much does NAD+ cost?

Research-grade NAD+ listed at $35.00 to $100.00 per 500 mg vial at the US suppliers we checked on November 17, 2026. Across 100 mg to 1,000 mg vials, prices ran from $0.07 to $0.47 per mg.

Is NAD+ a peptide?

No. NAD+ is nicotinamide adenine dinucleotide, a small molecule. Research suppliers sell it alongside peptides, in the same lyophilized vial format.

What does FDA’s category 1 mean for NAD?

Category 1 holds bulk drug substances nominated for pharmacy compounding under section 503A that FDA is still evaluating. FDA listed NAD there in its May 14, 2026 update. It says nothing about research-grade material.

Why are larger NAD+ vials cheaper per mg?

Much of the cost of a vial is fixed: filling, sealing, labeling and lot testing. Those costs are about the same at 100 mg or 1,000 mg, so they are spread over more milligrams in the larger size. Both suppliers in our check that sold several sizes priced the larger ones lower per mg.

Is a cheap NAD+ listing a bad sign?

Not by itself. Price differences between suppliers are normal and reflect testing, purity, vial size and overhead. An undefined formulation, missing identity data and no lot-specific certificate are the signals worth checking.

What to know now

  • NAD+ is not a peptide. It is a small molecule sold by research suppliers in the same vial format.
  • 500 mg vials listed at $35.00–$100.00. That was the range at the US research suppliers we checked on November 17, 2026.
  • Per mg, $0.07 to $0.47. Small vials cost the most per mg.
  • Vitrapep lists 500 mg at $74.99. That is $0.15 per mg, in the middle of the 500 mg listings.
  • Check the form and the lot. A stated formulation and a lot-specific certificate matter more than a discount.

What we’re watching

First, FDA’s evaluation of NAD in category 1 of the 503A nominations list. Second, supplier pricing. Quantity discounts and site-wide codes move effective prices often, and we will re-check these listings as they change.

Also in the library

More for endocrine & metabolism

All 38 compounds for endocrine & metabolism

Sources: National Center for Biotechnology Information. (n.d.). PubChem compound summary for CID 5892, PubChem compound summary for CID 5892, Nadide; U.S. Food and Drug Administration 2026; U.S. Food and Drug Administration 2023, Warning letter: Warrior Labz SARMS, MARCS-CMS 655280; MyPurePeptide. (n.d.). NAD+ 500mg [Product page]. Retrieved November 17, NAD+ 500mg; Purely Peptides. (n.d.). NAD+ (Buffered) 500mg [Product page]. Retrieved November 17, NAD+ (Buffered) 500mg; PS Peptides. (n.d.). NAD+ (1 vial) [Product page]. Retrieved November 17, NAD+ (1 vial); American Peptides. (n.d.). NAD+ [Product page]. Retrieved November 17, NAD+; Core Peptides. (n.d.). NAD+: 100MG / 250MG / 750MG [Product page]. Retrieved November 17, NAD+: 100MG / 250MG / 750MG. All 8 citations

Back to the research library

References

  1. National Center for Biotechnology Information. (n.d.). PubChem compound summary for CID 5892, Nadide. Retrieved November 17, 2026, from https://pubchem.ncbi.nlm.nih.gov/compound/5892
  2. U.S. Food and Drug Administration. (2026, May 14). Bulk drug substances nominated for use in compounding under section 503A of the Federal Food, Drug, and Cosmetic Act. https://www.fda.gov/media/94155/download
  3. U.S. Food and Drug Administration. (2023, June 12). Warning letter: Warrior Labz SARMS, MARCS-CMS 655280. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/warrior-labz-sarms-655280-06122023
  4. MyPurePeptide. (n.d.). NAD+ 500mg [Product page]. Retrieved November 17, 2026, from https://mypurepeptide.com/product/nad-500mg/
  5. Purely Peptides. (n.d.). NAD+ (Buffered) 500mg [Product page]. Retrieved November 17, 2026, from https://purelypeptides.org/product/nad-plus/
  6. PS Peptides. (n.d.). NAD+ (1 vial) [Product page]. Retrieved November 17, 2026, from https://pspeptides.com/product/buy-nad/
  7. American Peptides. (n.d.). NAD+ [Product page]. Retrieved November 17, 2026, from https://americanpeptides.us/products/nad
  8. Core Peptides. (n.d.). NAD+: 100MG / 250MG / 750MG [Product page]. Retrieved November 17, 2026, from https://www.corepeptides.com/peptides/nad-100mg-750mg/